DPP4 and metabolic syndrome: In summary, we have shown prospectively that increased fasting plasma DPP4 activity independently predict incident metabolic syndrome and insulin resistance in apparently healthy Chinese, and it may be considered as a novel marker of metabolic syndrome and insulin resistance.